Amicus Therapeutics
FOLD
FOLD
68 hedge funds and large institutions have $71M invested in Amicus Therapeutics in 2014 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 27 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
37% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 27
Holders
68
Holding in Top 10
–
Calls
$140K
Puts
$38K
Top Buyers
| 1 | +$2M | |
| 2 | +$554K | |
| 3 | +$523K | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$216K |
| 5 |
D.E. Shaw & Co
New York
|
+$111K |
Top Sellers
| 1 | -$944K | |
| 2 | -$659K | |
| 3 | -$623K | |
| 4 |
Renaissance Technologies
New York
|
-$575K |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$314K |